The RMEI baseline measurement was designed to measure the status of key indicators to capture performance along the trajectory of the “Detection, Diagnosis, Treatment, Investigation, and Response (DTI-R)” management strategy. These include the supply of inputs for diagnosis and treatment, the proportion of suspected cases tested for malaria, the timeliness of detection and treatment of confirmed cases, the frequency and quality of reporting of cases and laboratory production, and the coverage of vector control interventions carried out in households at risk of infection.

The RMEI baseline measurement was designed to measure the status of key indicators to capture performance along the trajectory of the “Detection, Diagnosis, Treatment, Investigation, and Response (DTI-R)” management strategy. These include the supply of inputs for diagnosis and treatment, the proportion of suspected cases tested for malaria, the timeliness of detection and treatment of confirmed cases, the frequency and quality of reporting of cases and laboratory production, and the coverage of vector control interventions carried out in households at risk of infection.

The RMEI baseline measurement was designed to measure the status of key indicators to capture performance along the trajectory of the “Detection, Diagnosis, Treatment, Investigation, and Response (DTI-R)” management strategy. These include the supply of inputs for diagnosis and treatment, the proportion of suspected cases tested for malaria, the timeliness of detection and treatment of confirmed cases, the frequency and quality of reporting of cases and laboratory production, and the coverage of vector control interventions carried out in households at risk of infection.

The RMEI baseline measurement was designed to measure the status of key indicators to capture performance along the trajectory of the “Detection, Diagnosis, Treatment, Investigation, and Response (DTI-R)” management strategy. These include the supply of inputs for diagnosis and treatment, the proportion of suspected cases tested for malaria, the timeliness of detection and treatment of confirmed cases, the frequency and quality of reporting of cases and laboratory production, and the coverage of vector control interventions carried out in households at risk of infection.

The RMEI baseline measurement was designed to measure the status of key indicators to capture performance along the trajectory of the “Detection, Diagnosis, Treatment, Investigation, and Response (DTI-R)” management strategy. These include the supply of inputs for diagnosis and treatment, the proportion of suspected cases tested for malaria, the timeliness of detection and treatment of confirmed cases, the frequency and quality of reporting of cases and laboratory production, and the coverage of vector control interventions carried out in households at risk of infection.

The RMEI baseline measurement was designed to measure the status of key indicators to capture performance along the trajectory of the “Detection, Diagnosis, Treatment, Investigation, and Response (DTI-R)” management strategy. These include the supply of inputs for diagnosis and treatment, the proportion of suspected cases tested for malaria, the timeliness of detection and treatment of confirmed cases, the frequency and quality of reporting of cases and laboratory production, and the coverage of vector control interventions carried out in households at risk of infection.

The RMEI baseline measurement was designed to measure the status of key indicators to capture performance along the trajectory of the “Detection, Diagnosis, Treatment, Investigation, and Response (DTI-R)” management strategy. These include the supply of inputs for diagnosis and treatment, the proportion of suspected cases tested for malaria, the timeliness of detection and treatment of confirmed cases, the frequency and quality of reporting of cases and laboratory production, and the coverage of vector control interventions carried out in households at risk of infection.

In malaria elimination settings, available metrics for malaria surveillance have been insufcient to measure the performance of passive case detection adequately. An indicator for malaria suspected cases with malaria test (MSCT) is proposed to measure the rate of testing on persons presenting to health facilities who satisfy the definition of a suspected malaria case.

Lado.MX

The Salud Mesoamerica Initiative (SMI) was a public-private regional partnership aimed at reducing inequities in access to and the quality of reproductive, maternal, neonatal, and child health (RMNCH) services in eight countries across Central America and Mexico. This initiative was a collaboration between the governments of these countries, the Bill Gates Foundation, the Carlos Slim Foundation, the governments of Canada and Spain, and the Inter-American Development Bank (IDB), which acted as the general administrator of the trust fund.